Premium
Use of NIMH for determination of dry weight and prevention of dialysis associated morbidity in children.
Author(s) -
Levtchenko E.,
Creemers D.,
Schaijk D.v.,
Rijbroek I.,
Schroder C.
Publication year - 2003
Publication title -
hemodialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 47
eISSN - 1542-4758
pISSN - 1492-7535
DOI - 10.1046/j.1492-7535.2003.01282.x
Subject(s) - medicine , hemodialysis , hematocrit , dialysis , blood volume , ultrafiltration (renal) , medical prescription , surgery , anesthesia , chemistry , chromatography , pharmacology
The majority of hemodialysis (HD) treatments incorporate a prescription for fluid removal targeted to a patients “dry” weight. Hypotension, cramps or headache often complicates fluid removal in children. The purpose of this study was to evaluate whether non‐invasive blood volume monitoring by hematocrit could be used for the determination of dry weight and prevention of intra‐dialytic complaints in children on chronic HD. Patients and methods : 128 dialysis sessions in 16 patients, aged 3–17 years, were evaluated. Non‐invasive monitoring of hematocrit (NIMH) (Crit‐line TM , HemaMetrics) was performed during the whole HD session and expressed as % Δ of blood volume (%BVΔ). Results : Changes in blood volume significantly correlated with the changes of patient's weight during hemodialysis treatments (p = 0.001). Thirty HD sessions were complicated by symptomatic hypotension in 12 patients. Conclusion: Changes in blood volume measured by Crit‐line correlate with the changes of patient's weight during hemodialysis treatments. Complicated HD sessions were associated with lower halfway %BVΔ. This indicates that NIMH might be useful for the determination of dry weight and for prevention of intra‐dialytic morbidity in children by remodeling of the ultrafiltration profile.